58981-35-4 Usage
Description
2-(4-METHYL-THIAZOL-5-YL)-ETHYLAMINE is an organic compound with the molecular formula C7H10N2S. It is a derivative of ethanamine, featuring a thiazol ring with a methyl group at the 4-position. 2-(4-METHYL-THIAZOL-5-YL)-ETHYLAMINE is known for its potential applications in the pharmaceutical and chemical industries due to its unique chemical structure and properties.
Uses
Used in Pharmaceutical Industry:
2-(4-METHYL-THIAZOL-5-YL)-ETHYLAMINE is used as a synthetic intermediate for the development of various histamine H2 agonists. These agonists have potential applications in the treatment of various medical conditions, such as peptic ulcers, allergies, and other disorders related to the histamine receptor.
Used in Chemical Research:
2-(4-METHYL-THIAZOL-5-YL)-ETHYLAMINE is also utilized in the synthesis of novel compounds for chemical research. Its unique structure allows for the exploration of new chemical reactions and the development of innovative molecules with potential applications in various fields, including pharmaceuticals, materials science, and agrochemicals.
Check Digit Verification of cas no
The CAS Registry Mumber 58981-35-4 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 5,8,9,8 and 1 respectively; the second part has 2 digits, 3 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 58981-35:
(7*5)+(6*8)+(5*9)+(4*8)+(3*1)+(2*3)+(1*5)=174
174 % 10 = 4
So 58981-35-4 is a valid CAS Registry Number.
InChI:InChI=1/C6H10N2S/c1-5-6(2-3-7)9-4-8-5/h4H,2-3,7H2,1H3
58981-35-4Relevant articles and documents
-
Price,Pickel
, p. 1067 (1941)
-
Evaluation of a Vitamin-Cloaking Strategy for Oligopeptide Therapeutics: Biotinylated HIV-1 Protease Inhibitors
Islam, Imadul,Ng, Ka-yun,Chong, Kong Teck,McQuade, Thomas J.,Hui, John O.,et al.
, p. 293 - 304 (2007/10/02)
The outstanding limitations to the oligopeptide as a therapeutic agent are poor oral availability and rapid biliary clearance.To address these concerns a series of eight peptidic HIV-1 protease inhibitors containing the structural segment of the vitamin b